C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,476 | -77.2% | 1,107 | -57.1% | 0.00% | -100.0% |
| Q4 2022 | $15,240 | -32.7% | 2,583 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,653 | +16.3% | 2,583 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,476 | -68.9% | 2,583 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $62,664 | -81.2% | 2,583 | -75.1% | 0.00% | -60.0% |
| Q4 2021 | $334,075 | -27.9% | 10,375 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $463,555 | +20.1% | 10,375 | +1.7% | 0.01% | +40.0% |
| Q2 2021 | $385,892 | +179.2% | 10,198 | +172.9% | 0.01% | +150.0% |
| Q1 2021 | $138,232 | +11.7% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $123,807 | – | 3,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |